Patient factors and quality of life outcomes differ among four subgroups of oncology patients based on symptom occurrence

References

• Esther Kim JE, Dodd MJ, Aouizerat BE, et al. A review of the prevalence and impact of multiple symptoms in oncology patients. J Pain Symptom Manage. 2009;37:715–736.
   PubMed Web of Science ®Google Scholar
• Gilbertson-White S, Aouizerat BE, Jahan T, et al. A review of the literature on multiple symptoms, their predictors, and associated outcomes in patients with advanced cancer. Pall Supp Care. 2011;9:81–102.
   PubMed Web of Science ®Google Scholar
• Ferreira KA, Kimura M, Teixeira MJ, et al. Impact of cancer-related symptom synergisms on health-related quality of life and performance status. J Pain Symptom Manage. 2008;35:604–616.
   PubMed Web of Science ®Google Scholar
• Gwede CK, Small BJ, Munster PN, et al. Exploring the differential experience of breast cancer treatment-related symptoms: a cluster analytic approach. Support Care Cancer. 2008;16:925–933.
   PubMed Web of Science ®Google Scholar
• Miaskowski C, Cooper BA, Paul SM, et al. Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. Oncol Nurs Forum. 2006;33:E79–E89.
   PubMedGoogle Scholar
• Pud D, Ben Ami S, Cooper BA, et al. The symptom experience of oncology outpatients has a different impact on quality-of-life outcomes. J Pain Symptom Manage. 2008;35:162–170.
   PubMed Web of Science ®Google Scholar
• Illi J, Miaskowski C, Cooper B, et al. Association between pro- and anti-inflammatory cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression. Cytokine. 2012;58:437–447.
   PubMed Web of Science ®Google Scholar
• Reese JB, Blackford A, Sussman J, et al. Cancer patients' function, symptoms and supportive care needs: a latent class analysis across cultures. Qual Life Res. 2015;24:135–146.
   PubMed Web of Science ®Google Scholar
• Snyder CF, Garrett-Mayer E, Blackford AL, et al. Concordance of cancer patients' function, symptoms, and supportive care needs. Qual Life Res. 2009;18:991–998.
   PubMed Web of Science ®Google Scholar
• Miaskowski C, Cooper BA, Melisko M, et al. Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapy. Cancer. 2014;120:2371–2378.
   PubMed Web of Science ®Google Scholar
• Miaskowski C, Dunn L, Ritchie C, et al. Latent class analysis reveals distinct subgroups of patients based on symptom occurrence and demographic and clinical characteristics. J Pain Symptom Manage. 2015;50:28–37.
   PubMed Web of Science ®Google Scholar
• Langford DJ, Paul SM, Cooper B, et al. Comparison of subgroups of breast cancer patients on pain and co-occurring symptoms following chemotherapy. Support Care Cancer. 2016;24:605–614.
   PubMed Web of Science ®Google Scholar
• Dodd MJ, Cho MH, Cooper BA, et al. Identification of latent classes in patients who are receiving biotherapy based on symptom experience and its effect on functional status and quality of life. Oncol Nurs Forum. 2011;38:33–42.
   PubMed Web of Science ®Google Scholar
• Doong SH, Dhruva A, Dunn LB, et al. Associations between cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression in patients prior to breast cancer surgery. Biol Res Nurs. 2015;17:237–247.
   PubMed Web of Science ®Google Scholar
• Miaskowski C, Cooper BA, Aouizerat B, et al. The symptom phenotype of oncology outpatients remains relatively stable from prior to through 1 week following chemotherapy. Eur J Cancer Care. 2016. doi: 10.1111/ecc.12437.
   PubMed Web of Science ®Google Scholar
• Karnofsky D. Performance scale. New York: Plenum Press; 1977.
   Google Scholar
• Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol. 1984;2:187–193.
   PubMed Web of Science ®Google Scholar
• Sangha O, Stucki G, Liang MH, et al. The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49:156–163.
   PubMed Web of Science ®Google Scholar
• Portenoy RK, Thaler HT, Kornblith AB, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994;36:1326–130A.
   Web of Science ®Google Scholar
• Hofso K, Rustoen T, Cooper BA, et al. Changes over time in occurrence, severity, and distress of common symptoms during and after radiation therapy for breast cancer. J Pain Symptom Manage. 2013;45:980–1006.
   PubMed Web of Science ®Google Scholar
• Ferrell BR, Wisdom C, Wenzl C. Quality of life as an outcome variable in the management of cancer pain. Cancer. 1989;63:2321–2327.
   PubMed Web of Science ®Google Scholar
• Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–233.
   PubMed Web of Science ®Google Scholar
• Padilla GV. Validity of health-related quality of life subscales. Prog Cardiovasc Nurs. 1992;7:13–20.
   PubMedGoogle Scholar
• Ware JE, Kosinski M, Keller SD. How to score the SF-12 physical and mental summary scales. Boston, MA: New England Medical Center, Health Institute; 1995.
   Google Scholar
• Gandek B, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51:1171–1178.
   PubMed Web of Science ®Google Scholar
• Muthén LK, Muthén BO. Mplus User’s Guide. 7th ed. Los Angeles, CA: Muthén & Muthén; 2012.
   Google Scholar
• Muthen B, Shedden K. Finite mixture modeling with mixture outcomes using the EM algorithm. Biometrics. 1999;55:463–469.
   PubMed Web of Science ®Google Scholar
• Vermunt JK, Magdison J. Latent class cluster analyses. New York: Cambridge University Press; 2002.
   Google Scholar
• Nylund KL, Asparouhov T, Muthen BO. Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study. Struct Equ Model. 2007;14:535–569.
   Web of Science ®Google Scholar
• Celeux GS. An entropy criterion for assessing the number of clusters in a mixture model. J Classification. 1996;13:195–212.
   Web of Science ®Google Scholar
• Cohen J. Statistical power analysis for the behavioral sciences. 2 ed. New Jersey: Lawrence Erlbaum Associates; 1988.
   Google Scholar
• Sloan JA, Frost MH, Berzon R, et al. The clinical significance of quality of life assessments in oncology: a summary for clinicians. Support Care Cancer. 2006;14:988–998.
   PubMed Web of Science ®Google Scholar